JPS57167914A - Remedy active to central nervous system - Google Patents

Remedy active to central nervous system

Info

Publication number
JPS57167914A
JPS57167914A JP4547682A JP4547682A JPS57167914A JP S57167914 A JPS57167914 A JP S57167914A JP 4547682 A JP4547682 A JP 4547682A JP 4547682 A JP4547682 A JP 4547682A JP S57167914 A JPS57167914 A JP S57167914A
Authority
JP
Japan
Prior art keywords
substd
opt
alkyl
alkenyl
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4547682A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6259090B2 (nl
Inventor
Tomine Mishieru
Biyurutoo Jieraaru
Ashie Jiyatsuku
Koriniyon Kuroodo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D'etudes Scientifiques & Ind De L'ile De Fr soc
Scient & Ind de l Ile De Fr So
Original Assignee
D'etudes Scientifiques & Ind De L'ile De Fr soc
Scient & Ind de l Ile De Fr So
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by D'etudes Scientifiques & Ind De L'ile De Fr soc, Scient & Ind de l Ile De Fr So filed Critical D'etudes Scientifiques & Ind De L'ile De Fr soc
Publication of JPS57167914A publication Critical patent/JPS57167914A/ja
Publication of JPS6259090B2 publication Critical patent/JPS6259090B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP4547682A 1976-08-04 1982-03-19 Remedy active to central nervous system Granted JPS57167914A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
JPS57167914A true JPS57167914A (en) 1982-10-16
JPS6259090B2 JPS6259090B2 (nl) 1987-12-09

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4547682A Granted JPS57167914A (en) 1976-08-04 1982-03-19 Remedy active to central nervous system

Country Status (37)

Country Link
JP (1) JPS57167914A (nl)
AR (1) AR219709A1 (nl)
AT (1) AT358034B (nl)
AU (1) AU516033B2 (nl)
BE (1) BE857350A (nl)
BG (1) BG36496A3 (nl)
CA (1) CA1114371A (nl)
CH (1) CH629198A5 (nl)
CS (1) CS216246B2 (nl)
DD (1) DD133237A5 (nl)
DE (1) DE2760414C2 (nl)
DK (1) DK152366C (nl)
EG (1) EG12716A (nl)
ES (1) ES461175A1 (nl)
FI (1) FI63938C (nl)
GR (1) GR61351B (nl)
HK (2) HK40382A (nl)
HU (1) HU179064B (nl)
IE (2) IE45647B1 (nl)
IL (2) IL52644A0 (nl)
IN (1) IN145473B (nl)
LU (1) LU77897A1 (nl)
MC (1) MC1154A1 (nl)
MW (1) MW2077A1 (nl)
NL (1) NL172063C (nl)
NO (1) NO152133C (nl)
NZ (1) NZ184816A (nl)
OA (1) OA05728A (nl)
PH (3) PH22114A (nl)
PL (1) PL111071B1 (nl)
PT (1) PT66865B (nl)
RO (1) RO72963A (nl)
SE (2) SE440776B (nl)
SU (1) SU716523A3 (nl)
YU (1) YU40005B (nl)
ZA (1) ZA774701B (nl)
ZM (1) ZM6077A1 (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017039659A (ja) * 2015-08-19 2017-02-23 株式会社トクヤマ ミルタザピンの製造方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017039659A (ja) * 2015-08-19 2017-02-23 株式会社トクヤマ ミルタザピンの製造方法

Also Published As

Publication number Publication date
NL172063B (nl) 1983-02-01
DK152366B (da) 1988-02-22
ZA774701B (en) 1979-01-31
LU77897A1 (nl) 1978-02-09
IN145473B (nl) 1978-10-21
ATA569677A (de) 1980-01-15
YU40005B (en) 1985-06-30
PH22114A (en) 1988-06-01
SE7708849L (sv) 1978-02-05
AU2750777A (en) 1979-02-08
MC1154A1 (fr) 1978-04-17
OA05728A (fr) 1981-05-31
CS216246B2 (en) 1982-10-29
AT358034B (de) 1980-08-11
SE437027B (sv) 1985-02-04
GR61351B (en) 1978-10-26
DK346977A (da) 1978-02-05
DD133237A5 (de) 1978-12-20
PL200066A1 (pl) 1978-09-11
BE857350A (fr) 1978-02-01
HU179064B (en) 1982-08-28
NZ184816A (en) 1980-11-14
MW2077A1 (en) 1978-12-13
SE8206546L (sv) 1982-11-17
IE45647B1 (en) 1982-10-20
SU716523A3 (ru) 1980-02-15
AU516033B2 (en) 1981-05-14
EG12716A (en) 1979-09-30
ES461175A1 (es) 1978-12-01
IL66138A0 (en) 1982-09-30
PH17710A (en) 1984-11-19
AR219709A1 (es) 1980-09-15
HK40382A (en) 1982-09-24
DE2760414C2 (nl) 1990-05-17
IL52644A0 (en) 1977-10-31
ZM6077A1 (en) 1979-05-21
PL111071B1 (en) 1980-08-30
NL172063C (nl) 1983-07-01
PT66865A (fr) 1977-08-01
HK40482A (en) 1982-09-24
SE440776B (sv) 1985-08-19
FI63938B (fi) 1983-05-31
CH629198A5 (fr) 1982-04-15
FI772362A (nl) 1978-02-05
NO152133B (no) 1985-04-29
CA1114371A (en) 1981-12-15
SE8206546D0 (sv) 1982-11-17
SE453390B (sv) 1988-02-01
NO772739L (no) 1978-02-07
IE802409L (en) 1978-02-04
IE45646L (en) 1978-02-04
YU188277A (en) 1983-01-21
DK152366C (da) 1988-07-25
NL7708616A (nl) 1978-02-07
PT66865B (fr) 1978-12-29
BG36496A3 (en) 1984-11-15
NO152133C (no) 1985-08-07
JPS6259090B2 (nl) 1987-12-09
RO72963A (ro) 1981-11-24
PH18629A (en) 1985-08-23
IE45646B1 (en) 1982-10-20
FI63938C (fi) 1983-09-12

Similar Documents

Publication Publication Date Title
FR2396757A2 (fr) Nouveaux 2,3-alkylene bis (oxy) benzamides substitues, leurs derives et leurs procedes de preparation
BR8303898A (pt) Compostos, processo para a fabricacao dos mesmos, medicamento e uso de tais compostos
FR2360305B1 (nl)
JPS57167914A (en) Remedy active to central nervous system
JPS5737594B2 (nl)
FR2421897A1 (fr) Nouveaux derives du thiophene, leur procede de preparation ainsi que les compositions therapeutiques les contenant